Intercostal Muscle Flap in Post Tuberculous Pneumonectomy: A New Technique

Alaa Brik, Abdel-Maged Salem, Osama Saber

Department of Cardiothoracic surgery, Zagazig University Hospital, Zagazig, Egypt.

DOI: 10.4236/ss.2012.35049                

Abstract

Objective: There are many risk factors for postoperative bronchopleural fistula (BPF), including extensive resection, diabetes, chronic infection, perioperative steroid therapy, preoperative chemotherapy, and radiotherapy, the risk of bronchopleural fistula increases with resection for inflammatory diseases, especially Mycobacterium tuberculosis (MTB). The aim of this study is to evaluate the efficacy and safety of using double pedicled intercostal muscle flaps with dual blood supply to buttress the bronchial stump after pneumonectomy for tuberculous lesions as a prophylactic new technique from post-pneumonectomy BPF. Methods: Between 2007 and 2011, 47 patients with pneumonectomy for post tuberculous lesions in the department of cardiothoracic surgery, Zagazig University Hospital were divided into two groups. Group A: 28 patients with single pedicled intercostal muscle flap used and applied on the bronchial stump after pneumonectomy. Group B: 19 patients with double pedicled intercostal muscle flaps used and applied on the bronchial stump. The mean age of the patients was 42.9 years (range 27 - 67 years) in Group A, 44.8 years (range 36 - 71 years) in Group B. Results: Bleeding in one patient in Group A (3.5%) and two patients in Group B (10.5%); empyema in two patients (7.1%) in Group A only one of them developed bronchopleural fistula; arrhythmias in one patients (3.5%) in Group A and one patient in Group B (5.2%); chylothorax in one patients (3.5%); Chronic chest pain in one patient in Group A (3.5%) and two patients in Group B (10.5%). The mean follow up period was 32.7 ± 12.9 months (range between 3 and 48 months). All patients remained symptom free with no evidence of late bronchopleural fistula in Group B. Conclusions: Double pedicled intercostal muscle flaps with dual blood supply buttressing the bronchial stump is new prophylactic technique from BPF after pneumonectomy for pulmonary tuberculous lesions in high risk patients.

Keywords

Intercostal Muscles; Pneumonectomy; Tuberculosis

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	H. Asamura, T. Naruke, R. Tsuchiya, T. Goya, H. Kondo and K. Suemasu, “Bronchopleural Fistulas Associated with Lung Cancer Operations. Univariate and Multivariate Analysis of Risk Factors, Management, and Outcome,” Journal of Thoracic and Cardiovascular Surgery, Vol. 104, No. 5, 1992, pp. 1456-1464.
[2]	W. C. Fowler, C. J. Langer, W. J. Curran Jr. and S. M. Keller, “Postoperative Complications after Combined Neo-Adjuvant Treatment of Lung Cancer,” Annals of Thoracic Surgery, Vol. 55, No. 4, 1993, pp. 986-989. doi:10.1016/0003-4975(93)90131-Z
[3]	M. Sonobe, M. Nakagawa, Ichinose M, Ikegami N, M. Nagasawa and T. Shindo, “Analysis of Risk Factors in Bronchopleural Fistula after Pulmonary Resection for Primary Lung Cancer,” European Journal Cardio-Thoracic Surgery, Vol. 18, No. 5, 2000, pp. 519-523. doi:10.1016/S1010-7940(00)00541-8
[4]	M. Ashour, “Pneumonectomy for Tuberculosis,” European Journal Cardio-Thoracic Surgery, Vol. 12, No. 2 1997, pp. 209-213. doi:10.1016/S1010-7940(97)00155-3
[5]	L. Eidus, A. G. Jessamin, E. S. Hershfield and D. M. Hellbecque, “A National Study to Determine the Prevalence of Drug Resistance in Newly Discovered Previously Untreated Cases,” Canadian Journal of Public Health, Vol. 69, No. 2, 1978, pp. 146-153.
[6]	M. D. Iseman, L. Madsen, M. Goble and M. Pomerantz, “Surgical intervention in the Treatment of Pulmonary Disease Caused by Drug-Resistant Mycobacterium Tuberculosis,” American Review of Respiratory Disease, Vol. 141, No. 3, 1990, pp. 623-625. doi:10.1164/ajrccm/141.3.623
[7]	D. Lardinois, A. Horsch, T. Krueger, M. Dusmet and H. Ris, “Mediastinal Reinforcement after Induction Therapy and Pneumonectomy: Comparison of Intercostals Muscle Versus Diaphragm Flaps,” European Journal Cardio-Thoracic Surgery, Vol. 21, No. 1, 2002, pp. 74-78. doi:10.1016/S1010-7940(01)01079-X
[8]	H. Sirbu, T. Busch, I. Aleksic, W. Schreiner, O. Oster and H. Dalichau, “Bronchopleural Fistula in the Surgery of Non-Small Cell Lung Cancer: Incidence, Risk Factors, and Management,” Annals of Thoracic and Cardiovascular Surgery, Vol. 7, No. 6, 2001, pp. 330-336.
[9]	C. D. Wright, J. C. Wain, D. J. Mathisen and H. C. Grillo, “Postpneumonectomy Bronchopleural Fistula after Sutured Bronchial Closure: Incidence, Risk Factors, and Management,” Journal of Thoracic and Cardiovascular Surgery, Vol. 112, No. 5, 1996, pp. 1367-1371. doi:10.1016/S0022-5223(96)70153-8
[10]	G. Massard, A. Dabbagh, J. M. Wihlm, R. Kessler, P. Barsotti, N. Roeslin and G. Morand, “Pneumonectomy for Chronic Infection Is a High-Risk Procedure,” Annals of Thoracic Surgery, Vol. 62, No. 4, 1996, pp. 1033-1037. doi:10.1016/0003-4975(96)00596-6
[11]	P. H. Hollaus, M. Huber, F. Lax, N. Peter, W. Bohm and S. P. Nestor, “Closure of Bronchopleural Fistula after Pneumonectomy with a Pedicled Intercostals Muscle Flap,” European Journal Cardio-Thoracic Surgery, Vol. 16, No. 2, 1999, pp. 181-186. doi:10.1016/S1010-7940(99)00164-5
[12]	S. Halezeroglu, M. Keles, A. Uysal, M. Celik, C. Senol, G. Haciibrahimoglu and B. Arman, “Factors Affecting Postoperative Morbidity and Mortality in Destroyed Lung,” Annals of Thoracic Surgery, Vol. 64, No. 6, 1997, pp. 1635-1638. doi:10.1016/S0003-4975(97)00999-5
[13]	T. Maniwa, Y. Saito, H. Kaneda and H. Imamura, “Bronchial Stump Reinforcement with the Intercostal Muscle Flap without Adverse Effects,” European Journal Cardio-Thoracic Surgery, Vol. 30, No. 4, 2006, pp. 652-656. doi:10.1016/j.ejcts.2006.07.023
[14]	A. Brik, A. Salem, A. Kamal, M. Abdel-Sadek, M. Essa, M. El Sharawy, A. Deebes and K. A. Bary, “Surgical Outcome of Pulmonary Aspergilloma,” European Journal Cardio-Thoracic Surgery, Vol. 34, No. 4, 2008, pp. 882-885. doi:10.1016/j.ejcts.2008.06.049